{
    "query": "Assess structural feasibility of Solid Lipid Nanoparticle Upadacitinib",
    "molecule_name": "Upadacitinib",
    "formulation_type": "Solid Lipid Nanoparticle (SLN)",
    "target_condition": "Atopic Dermatitis",
    "side_effect_mitigation": "Acneiform Eruption",
    "context": {
        "source": "EXP-02 Pivot from SEP-03 Failure",
        "evidence": [
            "Liposomal formulations failed stability checks (SR9=0.25).",
            "Solid Lipid Nanoparticles (SLN) composed of Cetyl Palmitate provide a rigid core at room temperature.",
            "Rigid matrix reduces drug leakage and improves entrapment efficiency for lipophilic drugs like Upadacitinib.",
            "Predicted to have higher thermodynamic stability than liposomes."
        ],
        "pivot_rationale": "Shift from fluid-state liposomes to solid-state matrix to correct the low SR9 score."
    }
}